Digital endpoints in clinical trials of Alzheimer’s disease and other neurodegenerative diseases: challenges and opportunities

Digital endpoints in clinical trials of Alzheimer’s disease and other neurodegenerative diseases: challenges and opportunities

Alzheimer’s disease (AD) and other neurodegenerative diseases such as Parkinson’s disease (PD) and Huntington’s disease (HD) are associated with progressive cognitive, motor, affective and consequently functional decline considerably affecting Activities of Daily Living (ADL) and quality of life. St...

Full description

Bibliographic Details
Main Authors:	Anna-Katharine Brem, Sajini Kuruppu, Casper de Boer, Marijn Muurling, Ana Diaz-Ponce, Dianne Gove, Jelena Curcic, Andrea Pilotto, Wan-Fai Ng, Nicholas Cummins, Kristina Malzbender, Vera J. M. Nies, Gul Erdemli, Johanna Graeber, Vaibhav A. Narayan, Lynn Rochester, Walter Maetzler, Dag Aarsland
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-06-01
Series:	Frontiers in Neurology
Subjects:	Alzheimer’s disease Parkinson’s disease Huntington’s disease neurodegenerative diseases dementia digital biomarker
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2023.1210974/full

Similar Items

Regulatory considerations for developing remote measurement technologies for Alzheimer’s disease research
by: Gül Erdemli, et al.
Published: (2024-09-01)

Broadened assessments, health education and cognitive aids in the remote memory clinic
by: Andrew P. Owens, et al.
Published: (2022-12-01)

Remote monitoring technologies in Alzheimer’s disease: design of the RADAR-AD study
by: Marijn Muurling, et al.
Published: (2021-04-01)

Unsupervised but not supervised gait parameters are related to fatigue in Parkinson’s disease: a pilot study
by: Andrea Pilotto, et al.
Published: (2023-11-01)

RADAR-AD: assessment of multiple remote monitoring technologies for early detection of Alzheimer’s disease
by: Manuel Lentzen, et al.
Published: (2025-01-01)

Augmented reality versus standard tests to assess cognition and function in early Alzheimer’s disease
by: Marijn Muurling, et al.
Published: (2023-12-01)

The combined effect of amyloid-β and tau biomarkers on brain atrophy in dementia with Lewy bodies
by: Carla Abdelnour, et al.
Published: (2020-01-01)

Feasibility and usability of remote monitoring in Alzheimer's disease
by: Marijn Muurling, et al.
Published: (2024-04-01)

Balance Impairments as Differential Markers of Dementia Disease Subtype
by: Ríona Mc Ardle, et al.
Published: (2021-03-01)

Protocol for a randomized, placebo-controlled, double-blind phase IIa study of the safety, tolerability, and symptomatic efficacy of the ROCK-inhibitor Fasudil in patients with Parkinson’s disease (ROCK-PD)
by: Andreas W. Wolff, et al.
Published: (2024-02-01)

Selecting Remote Measurement Technologies to Optimize Assessment of Function in Early Alzheimer's Disease: A Case Study
by: Andrew P. Owens, et al.
Published: (2020-11-01)

Differentiating traits and states identifies the importance of chronic neuropsychiatric symptoms for cognitive prognosis in mild dementia
by: Lasse M. Giil, et al.
Published: (2021-01-01)

Comparing Clinical Profiles in Alzheimer's Disease and Parkinson's Disease Dementia
by: Martin R. Farlow, et al.
Published: (2013-09-01)

Systems Biology Approaches to Understand the Host–Microbiome Interactions in Neurodegenerative Diseases
by: Dorines Rosario, et al.
Published: (2020-07-01)

Large-scale resting state network correlates of cognitive impairment in Parkinson’s disease and related dopaminergic deficits
by: Alexander V Lebedev, et al.
Published: (2014-04-01)

Clinical and Neuropsychological Differences between Mild Parkinson's Disease Dementia and Dementia with Lewy Bodies
by: Mariya Petrova, et al.
Published: (2015-05-01)

Parsing heterogeneity within dementia with Lewy bodies using clustering of biological, clinical, and demographic data
by: Carla Abdelnour, et al.
Published: (2022-01-01)

Gender differences in dopaminergic system dysfunction in de novo Parkinson's disease clinical subtypes
by: Cecilia Boccalini, et al.
Published: (2022-06-01)

A protocol to examine vision and gait in Parkinson’s disease: impact of cognition and response to visual cues [version 2; referees: 2 approved]
by: Samuel Stuart, et al.
Published: (2016-03-01)

Physical activity levels in cognitively normal and cognitively impaired oldest-old and the association with dementia risk factors: a pilot study
by: Marijn Muurling, et al.
Published: (2023-03-01)

Ethical challenges of using remote monitoring technologies for clinical research: A case study of the role of local research ethics committees in the RADAR-AD study.
by: Marijn Muurling, et al.
Published: (2023-01-01)

Correction: Ethical challenges of using remote monitoring technologies for clinical research: A case study of the role of local research ethics committees in the RADAR-AD study.
by: Marijn Muurling, et al.
Published: (2023-01-01)

Correlates of Subjective and Mild Cognitive Impairment: Depressive Symptoms and CSF Biomarkers
by: Ramune Grambaite, et al.
Published: (2013-09-01)

Apathy is associated with faster global cognitive decline and early nursing home admission in dementia with Lewy bodies
by: Monica H. Breitve, et al.
Published: (2018-08-01)

Frailty in Older Adults with Mild Dementia: Dementia with Lewy Bodies and Alzheimer’s Disease
by: Miguel Germán Borda, et al.
Published: (2019-04-01)

Investigating the Impact of Environment and Data Aggregation by Walking Bout Duration on Parkinson’s Disease Classification Using Machine Learning
by: Rana Zia Ur Rehman, et al.
Published: (2022-03-01)

Genetic risk for Alzheimer's disease, cognition, and mild behavioral impairment in healthy older adults
by: Byron Creese, et al.
Published: (2021-01-01)

Entropy of Real-World Gait in Parkinson’s Disease Determined from Wearable Sensors as a Digital Marker of Altered Ambulatory Behavior
by: Lucy Coates, et al.
Published: (2020-05-01)

Gait Progression Over 6 Years in Parkinson’s Disease: Effects of Age, Medication, and Pathology
by: Joanna Wilson, et al.
Published: (2020-10-01)

Inflammatory panel cytokines are elevated in the neocortex of late-stage Alzheimer’s disease but not Lewy body dementias
by: Yuek Ling Chai, et al.
Published: (2023-05-01)

Editorial: Maintain that brain - protecting and boosting cognitive flexibility
by: Barbara Colombo, et al.
Published: (2023-09-01)

Assessment of Social Behavior Using a Passive Monitoring App in Cognitively Normal and Cognitively Impaired Older Adults: Observational Study
by: Marijn Muurling, et al.
Published: (2022-05-01)

A Longitudinal Study of Neurocognition in Dementia with Lewy Bodies Compared to Alzheimer’s Disease
by: Monica H. Breitve, et al.
Published: (2018-03-01)

Wind-Blown Mosquitoes and Introduction of Japanese Encephalitis into Australia
by: Scott A. Ritchie, et al.
Published: (2001-10-01)

Perspectives of old-age and dementia researchers on communication with policymakers and public research funding decision-makers: an international cross-sectional survey
by: Peter Fusdahl, et al.
Published: (2024-12-01)

Cerebrospinal Fluid Alzheimer Markers in Depressed Elderly Subjects with and without Alzheimer’s Disease
by: Milica Gregoric Kramberger, et al.
Published: (2012-03-01)

The Role of Movement Analysis in Diagnosing and Monitoring Neurodegenerative Conditions: Insights from Gait and Postural Control
by: Christopher Buckley, et al.
Published: (2019-02-01)

Metal Exposure and SNCA rs356219 Polymorphism Associated With Parkinson Disease and Parkinsonism
by: Roberto G. Lucchini, et al.
Published: (2020-12-01)

Differential pharmacological effects on brain reactivity and plasticity in Alzheimer’s Disease
by: Anna-Katharine eBrem, et al.
Published: (2013-10-01)

Clinical and laboratory differences between pediatric hospitalized patients with sickle cell disease infected or not by SARS-CoV-2
by: Gabriella Mafra Elia, et al.
Published: (2023-03-01)